These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18283451)

  • 41. Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders.
    Kugaya A; Fujita M; Innis RB
    Ann Nucl Med; 2000 Feb; 14(1):1-9. PubMed ID: 10770574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine D2 receptor brain imaging in the neonatal period using 123I-IBZM SPECT.
    Tranquart F; Saliba E; Zimmer L; Barantin L; Lanneau M; Guilloteau D; Baulieu JL
    J Nucl Med; 1999 Dec; 40(12):2126-7. PubMed ID: 10616897
    [No Abstract]   [Full Text] [Related]  

  • 43. Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia.
    Schwarz J; Tatsch K; Vogl T; Kirsch CM; Trenkwalder C; Arnold G; Gasser T; Oertel WH
    Mov Disord; 1992; 7(1):58-61. PubMed ID: 1532631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual-radiotracer translational SPECT neuroimaging. Comparison of three methods for the simultaneous brain imaging of D
    Tsartsalis S; Tournier BB; Habiby S; Ben Hamadi M; Barca C; Ginovart N; Millet P
    Neuroimage; 2018 Aug; 176():528-540. PubMed ID: 29723640
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas.
    de Herder WW; Reijs AE; de Swart J; Kaandorp Y; Lamberts SW; Krenning EP; Kwekkeboom DJ
    Eur J Nucl Med; 1999 Jan; 26(1):46-50. PubMed ID: 9933661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis.
    De Koning MB; Bloemen OJ; Van Duin ED; Booij J; Abel KM; De Haan L; Linszen DH; Van Amelsvoort TA
    J Psychopharmacol; 2014 Jun; 28(6):553-60. PubMed ID: 24526133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy.
    Knudsen GM; Karlsborg M; Thomsen G; Krabbe K; Regeur L; Nygaard T; Videbaek C; Werdelin L
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1631-8. PubMed ID: 15583914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.
    Verhoeff NP; Kapucu O; Sokole-Busemann E; van Royen EA; Janssen AG
    J Nucl Med; 1993 Dec; 34(12):2076-84. PubMed ID: 8254390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis.
    Hierholzer J; Cordes M; Schelosky L; Richter W; Keske U; Venz S; Semmler W; Poewe W; Felix R
    J Nucl Med; 1994 Dec; 35(12):1921-7. PubMed ID: 7989970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging.
    Leslie WD; Abrams DN; Greenberg CR; Hobson D
    J Nucl Med; 1996 Oct; 37(10):1589-91. PubMed ID: 8862288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography.
    Walker Z; Costa DC; Janssen AG; Walker RW; Livingstone G; Katona CL
    Eur J Nucl Med; 1997 Jun; 24(6):609-14. PubMed ID: 9169566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 123I-IBZM SPECT: reconstruction methodology and results in parkinsonism and dystonia.
    Berding G; Gratz KF; Kolbe H; Meyer GJ; Dengler R; Knoop BO; Hundeshagen H
    Nuklearmedizin; 1994 Oct; 33(5):194-9. PubMed ID: 7997377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Visualization of extrastriatal dopamine D2 receptors in the human brain.
    Kessler RM; Mason NS; Votaw JR; De Paulis T; Clanton JA; Ansari MS; Schmidt DE; Manning RG; Bell RL
    Eur J Pharmacol; 1992 Nov; 223(1):105-7. PubMed ID: 1478255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. D2-receptor imaging with [123I]IBZM and single photon emission tomography in psychiatry: a survey of current status.
    Schlösser R; Schlegel S
    J Neural Transm Gen Sect; 1995; 99(1-3):173-85. PubMed ID: 8579803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imaging extrastriatal dopamine D(2) receptor occupancy by endogenous dopamine in healthy humans.
    Fujita M; Verhoeff NP; Varrone A; Zoghbi SS; Baldwin RM; Jatlow PA; Anderson GM; Seibyl JP; Innis RB
    Eur J Pharmacol; 2000 Jan; 387(2):179-88. PubMed ID: 10650158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [99mTc]TRODAT-1/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome.
    Hwang WJ; Yao WJ; Fu YK; Yang AS
    Psychiatry Res; 2008 Feb; 162(2):159-66. PubMed ID: 18248965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects.
    Verhoeff NP; Kapur S; Hussey D; Lee M; Christensen B; C Psych ; Papatheodorou G; Zipursky RB
    Neuropsychopharmacology; 2001 Aug; 25(2):213-23. PubMed ID: 11425505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.
    Schlösser R; Schlegel S; Hiemke C; Nickel O; Bockisch A; Rao ML; Hahn K
    Psychiatry Res; 1997 Sep; 75(2):103-14. PubMed ID: 9351492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
    Ichise M; Toyama H; Fornazzari L; Ballinger JR; Kirsh JC
    J Nucl Med; 1993 Aug; 34(8):1274-81. PubMed ID: 8326384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of motor activity on striatal dopamine release: A study using iodobenzamide and SPECT.
    Larisch R; Schommartz B; Vosberg H; Müller-Gärtner HW
    Neuroimage; 1999 Sep; 10(3 Pt 1):261-8. PubMed ID: 10458941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.